We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Biocompatible Spinal Spacer Implant

By HospiMedica staff writers
Posted on 14 Jun 2006
A new vertebral body replacement (VBR) spinal spacer implant offers maximum bony in-growth area while maintaining implant structural strength.

The Crystal VBR spinal spacer implant, manufactured by Quantum Orthopedics (Carlsbad, CA, USA), features generous grafting windows and a large interior graft space for optimal performance. More...
The implants are radiolucent with radio-dense markers to enable accurate positioning and placement, and are available in seven heights angled 0° and 7°. Additionally, the VBR implants feature uni-directional ridges designed to prevent implant migration. The Crystal spinal spacers are made from Peek-Optima, a biocompatible and stable polyetherketone polymer manufactured by Invibio (Lancashire, UK). The system includes a color-coded instrument system designed to enable the surgeon to safely and quickly perform the procedure. The system has been approved by the U.S. Food and Drug Administration (FDA).

"The Crystal VBR is one of several products we will be introducing this year as Quantum Orthopedics broadens its product offering. This product adds to a successful line of vertebral body replacement devices that we currently offer,” said Todd Andres, president and CEO of Quantum Orthopedics.

Invibio's Peek-Optima polymer is used in the development of implantable medical devices and pharmaceutical applications having blood or tissue contact for more than 30 days. It is available in a range of forms that offer virtually unlimited design solutions.



Related Links:
Quantum Orthopedics
Invibio

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.